葛根素

Puerarin

未知生产厂商

Puerarin has been investigated for the treatment of Alcohol Abuse.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Puerarin has been investigated for the treatment of Alcohol Abuse.

用于辅助治疗冠心病、心绞痛、心肌梗死，视网膜动、静脉阻塞、突发性耳聋、血性脑血管病、小儿病毒性心肌炎、糖尿病等。眼科用于原发性开角型青光眼、高眼压症、原发性闭角型青光眼、继发性青光眼。

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Use of kudzu root ,kudzu root flavone and puerarin for prevention and cure of osteoporosis
CN 1164297 C申请人: WANG WEILIN优先权: 2001
CN
2 件公开
New process for extracting high purity puerarin by pure water method
CN 1162421 C申请人: HUNAN JOHNSON PHARM CO LTD优先权: 2002
CN
2 件公开
Hydrogen bond receptor type spherical polymeric adsorbent and method for extracting puerarin
CN 1164631 C申请人: OU LAILIANG优先权: 2002
CN
2 件公开
Puerarin preparing process
CN 1169820 C申请人: KUNMING INST BOTANY CN ACAD优先权: 2002
CN
2 件公开
葛根素载药微球、口服减肥代餐粉、制备方法及应用
CN 116036023 B申请人: 湖北万松堂大健康医药集团有限公司优先权: 2022
CN
2 件公开
一种提高葛根素生物利用度的方法
CN 116621824 B申请人: 中国医学科学院医药生物技术研究所优先权: 2023
CN
2 件公开
Preparation of compound puerarin
CN 1480172 A申请人: ANKANG RES INST OF MEDICINE BE优先权: 2002
CN
Puerarin oral preparation
CN 1615899 B申请人: INST PHARM & TOXICOLOGY AMMS优先权: 2003
CN
Compound notoginsen triterpenes puerarin preparation
CN 1836680 A申请人: YUNNAN YIYAO TECHNOLOGY DEV CO优先权: 2005
CN
Slow release preparation of puerarin
CN 101006988 A申请人: LIU FENGMING优先权: 2005
CN